{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:59:46Z","timestamp":1777903186702,"version":"3.51.4"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,1]]},"DOI":"10.7759\/cureus.108090","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:51:08Z","timestamp":1777636268000},"source":"Crossref","is-referenced-by-count":0,"title":["Association of LDLR rs688 Polymorphism With Dyslipidemia in End-Stage Renal Disease: A Case-Control Study"],"prefix":"10.7759","author":[{"given":"Johnsi","family":"Priya J","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aliya","family":"Nusrath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramya","family":"P","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sachin","family":"B S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inchara","family":"S","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.31","article-title":"KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient","volume":"85","author":"Wanner C","year":"2014","unstructured":"Wanner C, Tonelli M. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int. 2014, 85:1303-9. 10.1038\/ki.2014.31","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner C","year":"2005","unstructured":"Wanner C, Krane V, M\u00e4rz W, Olschewski M, Mann JF, Ruf G, Ritz E. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med. 2005, 353:238-48. 10.1056\/NEJMoa043545","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m BC","year":"2009","unstructured":"Fellstr\u00f6m BC, Jardine AG, Schmieder RE, et al.. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med. 2009, 360:1395-407. 10.1056\/NEJMoa0810177","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent C","year":"2011","unstructured":"Baigent C, Landray MJ, Reith C, et al.. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial. Lancet. 2011, 377:2181-92. 10.1016\/S0140-6736(11)60739-3","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(12)80030-8","article-title":"Lipoprotein metabolism and renal failure","volume":"21","author":"Attman PO","year":"1993","unstructured":"Attman PO, Samuelsson O, Alaupovic P. Lipoprotein metabolism and renal failure. Am J Kidney Dis. 1993, 21:573-92. 10.1016\/s0272-6386(12)80030-8","journal-title":"Am J Kidney Dis"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.00099.2005","article-title":"Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences","volume":"290","author":"Vaziri ND","year":"2006","unstructured":"Vaziri ND. Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. Am J Physiol Renal Physiol. 2006, 290:F262-72. 10.1152\/ajprenal.00099.2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.2147\/IJNRD.S101808","article-title":"Dyslipidemia in patients with chronic kidney disease: etiology and management","volume":"10","author":"Mikolasevic I","year":"2017","unstructured":"Mikolasevic I, \u017dutelija M, Mavrinac V, Orlic L. Dyslipidemia in patients with chronic kidney disease: etiology and management. Int J Nephrol Renovasc Dis. 2017, 10:35-45. 10.2147\/IJNRD.S101808","journal-title":"Int J Nephrol Renovasc Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-021-02532-6","article-title":"LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients","volume":"22","author":"Buraczynska M","year":"2021","unstructured":"Buraczynska M, Jacob J, Gwiazda-Tyndel K, Ksiazek A. LDLR gene polymorphism (rs688) affects susceptibility to cardiovascular disease in end-stage kidney disease patients. BMC Nephrol. 2021, 22:316. 10.1186\/s12882-021-02532-6","journal-title":"BMC Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-277079","article-title":"Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile","volume":"116","author":"Martinelli N","year":"2010","unstructured":"Martinelli N, Girelli D, Lunghi B, et al.. Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile. Blood. 2010, 116:5688-97. 10.1182\/blood-2010-03-277079","journal-title":"Blood"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcdd5020031","article-title":"LDLR rs688 TT genotype and T allele are associated with increased susceptibility to coronary artery disease-a case-control study","volume":"5","author":"Jha CK","year":"2018","unstructured":"Jha CK, Mir R, Khullar N, Banu S, Chahal SM. LDLR rs688 TT genotype and T allele are associated with increased susceptibility to coronary artery disease-a case-control study. J Cardiovasc Dev Dis. 2018, 5:31. 10.3390\/jcdd5020031","journal-title":"J Cardiovasc Dev Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm124","article-title":"A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol","volume":"16","author":"Zhu H","year":"2007","unstructured":"Zhu H, Tucker HM, Grear KE, Simpson JF, Manning AK, Cupples LA, Estus S. A common polymorphism decreases low-density lipoprotein receptor exon 12 splicing efficiency and associates with increased cholesterol. Hum Mol Genet. 2007, 16:1765-72. 10.1093\/hmg\/ddm124","journal-title":"Hum Mol Genet"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/dds559","article-title":"A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function","volume":"22","author":"Gao F","year":"2013","unstructured":"Gao F, Ihn HE, Medina MW, Krauss RM. A common polymorphism in the LDL receptor gene has multiple effects on LDL receptor function. Hum Mol Genet. 2013, 22:1424-31. 10.1093\/hmg\/dds559","journal-title":"Hum Mol Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/medsci7070080","article-title":"LDLR gene polymorphisms (rs5925 and rs1529729) are associated with susceptibility to coronary artery disease in a South Indian population","volume":"7","author":"K Jha C","year":"2019","unstructured":"K Jha C, Mir R, Elfaki I, Banu S, Chahal SM. LDLR gene polymorphisms (rs5925 and rs1529729) are associated with susceptibility to coronary artery disease in a South Indian population. Med Sci (Basel). 2019, 7:80. 10.3390\/medsci7070080","journal-title":"Med Sci (Basel)"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich TM","year":"2010","unstructured":"Teslovich TM, Musunuru K, Smith AV, et al.. Biological, clinical and population relevance of 95 loci for blood lipids. Nature. 2010, 466:707-13. 10.1038\/nature09270","journal-title":"Nature"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/1076029614568714","article-title":"Elevated levels of LDL-C are associated with ApoE4 but not with the rs688 polymorphism in the LDLR gene","volume":"22","author":"Cahua-Pablo G","year":"2016","unstructured":"Cahua-Pablo G, Cruz M, Moral-Hern\u00e1ndez OD, et al.. Elevated levels of LDL-C are associated with ApoE4 but not with the rs688 polymorphism in the LDLR gene. Clin Appl Thromb Hemost. 2016, 22:465-70. 10.1177\/1076029614568714","journal-title":"Clin Appl Thromb Hemost"},{"key":"ref16","article-title":"Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis","volume":"85","author":"Go GW","year":"2012","unstructured":"Go GW, Mani A. Low-density lipoprotein receptor (LDLR) family orchestrates cholesterol homeostasis. Yale J Biol Med. 2012, 85:19-28.","journal-title":"Yale J Biol Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-007-0327-1","article-title":"Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study","volume":"121","author":"Muallem H","year":"2007","unstructured":"Muallem H, North KE, Kakoki M, et al.. Quantitative effects of common genetic variations in the 3'UTR of the human LDL-receptor gene and their associations with plasma lipid levels in the Atherosclerosis Risk in Communities study. Hum Genet. 2007, 121:421-31. 10.1007\/s00439-007-0327-1","journal-title":"Hum Genet"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.2012.00724.x","article-title":"Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment","volume":"76","author":"Usifo E","year":"2012","unstructured":"Usifo E, Leigh SE, Whittall RA, et al.. Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment. Ann Hum Genet. 2012, 76:387-401. 10.1111\/j.1469-1809.2012.00724.x","journal-title":"Ann Hum Genet"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00657.x","article-title":"Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study","volume":"65","author":"Cheung AK","year":"2004","unstructured":"Cheung AK, Sarnak MJ, Yan G, et al.. Cardiac diseases in maintenance hemodialysis patients: results of the HEMO Study. Kidney Int. 2004, 65:2380-9. 10.1111\/j.1523-1755.2004.00657.x","journal-title":"Kidney Int"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-019-01718-5","article-title":"Characteristics of coronary artery disease in chronic kidney disease","volume":"23","author":"Fujii H","year":"2019","unstructured":"Fujii H, Kono K, Nishi S. Characteristics of coronary artery disease in chronic kidney disease. Clin Exp Nephrol. 2019, 23:725-32. 10.1007\/s10157-019-01718-5","journal-title":"Clin Exp Nephrol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/478614-association-of-ldlr-rs688-polymorphism-with-dyslipidemia-in-end-stage-renal-disease-a-case-control-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T11:51:09Z","timestamp":1777636269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/478614-association-of-ldlr-rs688-polymorphism-with-dyslipidemia-in-end-stage-renal-disease-a-case-control-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,1]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.108090","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5,1]]}}}